Your session is about to expire
← Back to Search
Meal Effects on Nutrient Tracking (Microdialysis Trial)
N/A
Recruiting
Led By Nicolaas Deutz, MD, PhD
Research Sponsored by Texas A&M University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ability to walk, sit down and stand up independently
Age 50-75 years old
Must not have
Established diagnosis of malignancy
Established diagnosis of Insulin or non-Insulin Dependent Diabetes Mellitus
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 hours per study visit, up to 4 visits
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to understand how the food we eat affects the levels of certain markers in our blood and tissue fluid. It will also test new devices and algorithms to track individual nutrient levels in real time.
Who is the study for?
This trial is for individuals with diabetes and issues with amino acid metabolism. Participants should be willing to fast before study days, undergo body measurements like weight and height, and have their diet, physical activity, and quality of life assessed.
What is being tested?
The trial aims to link the intake of specific macronutrients (proteins, fats, carbohydrates) in meals to changes in blood markers. It tests if wearable devices can track these nutrients effectively by using four different meal sets labeled A through D.
What are the potential side effects?
Since this study involves dietary assessment rather than medication or invasive procedures, side effects are minimal but may include discomfort from fasting or minor reactions to the wearable device.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can walk, sit, and stand on my own.
Select...
I am between 50 and 75 years old.
Select...
I can lie on my back or slightly raised for about 13 hours.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with cancer.
Select...
I have been diagnosed with diabetes.
Select...
I have never been treated for liver or kidney diseases.
Select...
I am currently taking blood thinners.
Select...
I have a history of blood clots or clotting disorders.
Select...
I have a severe illness or an unstable chronic condition.
Select...
I have not had a heart attack in the last year.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 14 hours per study visit, up to 4 visits
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 hours per study visit, up to 4 visits
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Glucose metabolism
Secondary study objectives
Amino acid metabolism
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Healthy male older adultsExperimental Treatment4 Interventions
Eight predefined, commercially available meal is administered in a randomized fashion. Two meals are consumed 6 hours apart on each study day. Meals are selected to represent a range of fat, protein, and carbohydrate content.
Group II: Healthy female older adultsExperimental Treatment4 Interventions
Eight predefined, commercially available meal is administered in a randomized fashion. Two meals are consumed 6 hours apart on each study day. Meals are selected to represent a range of fat, protein, and carbohydrate content.
Find a Location
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,464 Previous Clinical Trials
4,337,420 Total Patients Enrolled
109 Trials studying Diabetes
138,677 Patients Enrolled for Diabetes
Texas A&M UniversityLead Sponsor
149 Previous Clinical Trials
26,434 Total Patients Enrolled
2 Trials studying Diabetes
3,167 Patients Enrolled for Diabetes
Nicolaas Deutz, MD, PhDPrincipal InvestigatorTexas A&M University
1 Previous Clinical Trials
100 Total Patients Enrolled
Michael McShane, PhDPrincipal InvestigatorTexas A&M University